Generate Biomedicines, Inc. (GENB)
17.72
+1.60
(+9.93%)
USD |
NASDAQ |
Aug 24, 16:00
17.62
-0.10
(-0.56%)
After-Hours: 20:00
Generate Biomedicines Shareholders Equity (Quarterly) : 456.04M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 456.04M |
| Date | Value |
|---|---|
| March 31, 2026 | 514.80M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Twist Bioscience Corp. | 445.74M |
| Prime Medicine, Inc. | 39.81M |
| Intellia Therapeutics, Inc. | 727.71M |
| Beam Therapeutics, Inc. | 1.067B |
| Moderna, Inc. | 6.761B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 561.69M |
| Total Liabilities (Quarterly) | 105.64M |
| Debt to Equity Ratio | 0.1373 |
| Current Ratio | 8.303 |
| Net Debt Paydown Yield | -0.47% |